Erlotinib and Gemcitabine With or Without Panitumumab in Treating Patients With Metastatic Pancreatic Cancer
Randomized Phase II Trial of Panitumumab, Erlotinib and Gemcitabine vs. Erlotinib and Gemcitabine in Patients With Untreated, Metastatic Pancreatic Adenocarcinoma
RATIONALE: Drugs used in chemotherapy, such as gemcitabine, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Erlotinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Monoclonal antibodies, such as panitumumab, can block tumor growth in different ways. Some block the ability of tumor cells to grow and spread. Others find tumor cells and help kill them or carry tumor-killing substances to them. Panitumumab may also stop the growth of pancreatic cancer by blocking blood flow to the tumor.
PURPOSE: This randomized phase II trial is studying how well giving panitumumab together with gemcitabine and erlotinib works compared to giving gemcitabine and erlotinib alone in treating patients with metastatic pancreatic cancer.
研究概览
详细说明
OBJECTIVES:
Primary
- To assess whether the addition of panitumumab (a dual-epidermal growth factor receptor inhibitor) to standard chemotherapy comprising gemcitabine hydrochloride and erlotinib hydrochloride results in an improvement in overall survival of patients with previously untreated, metastatic adenocarcinoma of the pancreas.
Secondary
- To compare objective response rates, progression-free survival, time to treatment failure, quality of life, and adverse event rates in patients treated with these regimens.
- To evaluate the downstream marker, KRAS, in stool specimens.
OUTLINE: This is a multicenter study. Patients are stratified according to ECOG performance status (0 vs 1) and prior adjuvant chemotherapy (yes vs no). The first 6 patients are assigned to arm II. Subsequent patients are randomized to 1 of 2 treatment arms.
- Arm I: Patients receive gemcitabine hydrochloride IV over 30 minutes on days 1, 8, and 15 and oral erlotinib hydrochloride once daily on days 1-28. Treatment repeats every 28 days for 2 courses. Patients achieving a complete response (CR) after 2 courses receive 2 additional courses of treatment; patients achieving a partial response (PR) receive retreatment as above in the absence of disease progression or unacceptable toxicity. Patients achieving a CR after 4 courses of treatment receive maintenance therapy comprising erlotinib hydrochloride daily until the first disease progression. After the first progression, patients are retreated with gemcitabine hydrochloride and erlotinib hydrochloride until second progression (using the first progression tumor measurements as the new baseline reference).
- Arm II: Patients receive gemcitabine hydrochloride and erlotinib hydrochloride as in arm I and panitumumab IV over 1 hour on days 1 and 15. Treatment repeats every 28 days for 2 courses. Patients achieving a CR after 2 courses receive 2 additional courses of treatment; patients achieving a PR receive retreatment as above in the absence of disease progression or unacceptable toxicity. Patients achieving a CR after 4 courses of treatment receive maintenance therapy comprising erlotinib hydrochloride daily and panitumumab every 2 weeks until the first disease progression. After the first progression, patients are retreated with gemcitabine hydrochloride, erlotinib hydrochloride, and panitumumab until second progression (using the first progression tumor measurements as the new baseline reference).
Stool samples are collected at baseline and analyzed for KRAS mutations via protein analyses.
Quality of life will be assessed at baseline, every 2 courses during treatment, and at the end of treatment.
After the second progression, patients are followed every 3-6 months for 2 years.
研究类型
注册 (实际的)
阶段
- 阶段2
联系人和位置
学习地点
-
-
Colorado
-
Aurora、Colorado、美国、80012
- Aurora Presbyterian Hospital
-
Boulder、Colorado、美国、80301-9019
- Boulder Community Hospital
-
Colorado Springs、Colorado、美国、80933
- Penrose Cancer Center at Penrose Hospital
-
Denver、Colorado、美国、80210
- Porter Adventist Hospital
-
Denver、Colorado、美国、80220
- Rose Medical Center
-
Denver、Colorado、美国、80218
- Presbyterian - St. Luke's Medical Center
-
Denver、Colorado、美国、80204
- St. Anthony Central Hospital
-
Denver、Colorado、美国、80218
- St. Joseph Hospital
-
Denver、Colorado、美国、80224-2522
- CCOP - Colorado Cancer Research Program
-
Englewood、Colorado、美国、80110
- Swedish Medical Center
-
Fort Collins、Colorado、美国、80528
- Front Range Cancer Specialists
-
Grand Junction、Colorado、美国、81502
- St. Mary's Regional Cancer Center at St. Mary's Hospital and Medical Center
-
Greeley、Colorado、美国、80631
- North Colorado Medical Center
-
Lone Tree、Colorado、美国、80124
- Sky Ridge Medical Center
-
Longmont、Colorado、美国、80501
- Hope Cancer Care Center at Longmont United Hospital
-
Loveland、Colorado、美国、80539
- McKee Medical Center
-
Thornton、Colorado、美国、80229
- North Suburban Medical Center
-
Wheat Ridge、Colorado、美国、80033
- Exempla Lutheran Medical Center
-
-
Connecticut
-
Hartford、Connecticut、美国、06105
- Saint Francis/Mount Sinai Regional Cancer Center at Saint Francis Hospital and Medical Center
-
-
Florida
-
Jacksonville、Florida、美国、32224
- Mayo Clinic - Jacksonville
-
-
Hawaii
-
Aiea、Hawaii、美国、96701
- Kapiolani Medical Center at Pali Momi
-
Honolulu、Hawaii、美国、96813
- Cancer Research Center of Hawaii
-
Honolulu、Hawaii、美国、96826
- Kapiolani Medical Center for Women and Children
-
Honolulu、Hawaii、美国、96813
- OnCare Hawaii, Incorporated - Lusitana
-
Honolulu、Hawaii、美国、96813
- Queen's Cancer Institute at Queen's Medical Center
-
Honolulu、Hawaii、美国、96813
- Straub Clinic and Hospital, Incorporated
-
Honolulu、Hawaii、美国、96817
- Hawaii Medical Center - East
-
Honolulu、Hawaii、美国、96817
- OnCare Hawaii, Incorporated - Kuakini
-
Wailuku、Hawaii、美国、96793
- Pacific Cancer Institute - Maui
-
-
Illinois
-
Bloomington、Illinois、美国、61701
- St. Joseph Medical Center
-
Bloomington%、Illinois、美国、61701
- Illinois CancerCare - Bloomington
-
Canton、Illinois、美国、61520
- Illinois CancerCare - Canton
-
Canton、Illinois、美国、61520
- Graham Hospital
-
Carthage、Illinois、美国、62321
- Memorial Hospital
-
Carthage、Illinois、美国、62321
- Illinois CancerCare - Carthage
-
Eureka、Illinois、美国、61530
- Illinois CancerCare - Eureka
-
Eureka、Illinois、美国、61530
- Eureka Community Hospital
-
Galesburg、Illinois、美国、61401
- Illinois CancerCare - Galesburg
-
Galesburg、Illinois、美国、61401
- Galesburg Clinic, PC
-
Havana、Illinois、美国、62644
- Mason District Hospital
-
Havana、Illinois、美国、62644
- Illinois CancerCare - Havana
-
Kewanee、Illinois、美国、61443
- Illinois CancerCare - Kewanee Clinic
-
Macomb、Illinois、美国、61455
- Illinois CancerCare - Macomb
-
Macomb、Illinois、美国、61455
- Mcdonough District Hospital
-
Moline、Illinois、美国、61265
-
Moline、Illinois、美国、61265
- Trinity Cancer Center at Trinity Medical Center - 7th Street Campus
-
Monmouth、Illinois、美国、61462
- Illinois CancerCare - Monmouth
-
Normal、Illinois、美国、61761
- Bromenn Regional Medical Center
-
Normal、Illinois、美国、61761
- Community Cancer Center
-
Normal、Illinois、美国、61761
- Illinois CancerCare - Community Cancer Center
-
Ottawa、Illinois、美国、61350
- Community Hospital of Ottawa
-
Ottawa、Illinois、美国、61350
- Oncology Hematology Associates of Central Illinois, PC - Ottawa
-
Pekin、Illinois、美国、61554
- Cancer Treatment Center at Pekin Hospital
-
Pekin、Illinois、美国、61603
- Illinois CancerCare - Pekin
-
Peoria、Illinois、美国、61636
- Methodist Medical Center of Illinois
-
Peoria、Illinois、美国、61614
- Proctor Hospital
-
Peoria、Illinois、美国、61637
- OSF St. Francis Medical Center
-
Peoria、Illinois、美国、61615
- CCOP - Illinois Oncology Research Association
-
Peoria、Illinois、美国、61615
- Oncology Hematology Associates of Central Illinois, PC - Peoria
-
Peru、Illinois、美国、61354
- Illinois CancerCare - Peru
-
Peru、Illinois、美国、61354
- Illinois Valley Community Hospital
-
Princeton、Illinois、美国、61356
- Perry Memorial Hospital
-
Princeton、Illinois、美国、61356
- Illinois CancerCare - Princeton
-
Spring Valley、Illinois、美国、61362
- Illinois CancerCare - Spring Valley
-
-
Indiana
-
Beech Grove、Indiana、美国、46107
- St. Francis Hospital and Health Centers - Beech Grove Campus
-
Elkhart、Indiana、美国、46515
- Elkhart General Hospital
-
Elkhart、Indiana、美国、46514-2098
- Elkhart Clinic, LLC
-
Kokomo、Indiana、美国、46904
- Howard Community Hospital
-
La Porte、Indiana、美国、46350
- Center for Cancer Therapy at LaPorte Hospital and Health Services
-
Richmond、Indiana、美国、47374
- Reid Hospital & Health Care Services
-
South Bend、Indiana、美国、46601
- Memorial Hospital of South Bend
-
South Bend、Indiana、美国、46601
- CCOP - Northern Indiana CR Consortium
-
South Bend、Indiana、美国、46617
- Saint Joseph Regional Medical Center
-
South Bend、Indiana、美国、46617
- South Bend Clinic
-
South Bend、Indiana、美国、46601
- Michiana Hematology-Oncology, PC - South Bend
-
-
Iowa
-
Ames、Iowa、美国、50010
- McFarland Clinic, PC
-
Bettendorf、Iowa、美国、52722
-
Cedar Rapids、Iowa、美国、52403
- Cedar Rapids Oncology Associates
-
Cedar Rapids、Iowa、美国、52403
- Mercy Regional Cancer Center at Mercy Medical Center
-
Clive、Iowa、美国、50325
- Medical Oncology and Hematology Associates - West Des Moines
-
Des Moines、Iowa、美国、50309
- CCOP - Iowa Oncology Research Association
-
Des Moines、Iowa、美国、50309
- John Stoddard Cancer Center at Iowa Methodist Medical Center
-
Des Moines、Iowa、美国、50309
- Medical Oncology and Hematology Associates at John Stoddard Cancer Center
-
Des Moines、Iowa、美国、50314
- Medical Oncology and Hematology Associates at Mercy Cancer Center
-
Des Moines、Iowa、美国、50314
- Mercy Cancer Center at Mercy Medical Center - Des Moines
-
Des Moines、Iowa、美国、50316
- John Stoddard Cancer Center at Iowa Lutheran Hospital
-
Des Moines、Iowa、美国、50307
- Mercy Capitol Hospital
-
Sioux City、Iowa、美国、51101
- Siouxland Hematology-Oncology Associates, LLP
-
Sioux City、Iowa、美国、51104
- St. Luke's Regional Medical Center
-
Sioux City、Iowa、美国、51104
- Mercy Medical Center - Sioux City
-
-
Kansas
-
Chanute、Kansas、美国、66720
- Cancer Center of Kansas, PA - Chanute
-
Dodge City、Kansas、美国、67801
- Cancer Center of Kansas, PA - Dodge City
-
El Dorado、Kansas、美国、67042
- Cancer Center of Kansas, PA - El Dorado
-
Fort Scott、Kansas、美国、66701
- Cancer Center of Kansas - Fort Scott
-
Independence、Kansas、美国、67301
- Cancer Center of Kansas-Independence
-
Kingman、Kansas、美国、67068
- Cancer Center of Kansas, PA - Kingman
-
Lawrence、Kansas、美国、66044
- Lawrence Memorial Hospital
-
Liberal、Kansas、美国、67905
- Cancer Center of Kansas, PA - Liberal
-
Newton、Kansas、美国、67114
- Cancer Center of Kansas, PA - Newton
-
Parsons、Kansas、美国、67357
- Cancer Center of Kansas, PA - Parsons
-
Pratt、Kansas、美国、67124
- Cancer Center of Kansas, PA - Pratt
-
Salina、Kansas、美国、67401
- Cancer Center of Kansas, PA - Salina
-
Wellington、Kansas、美国、67152
- Cancer Center of Kansas, PA - Wellington
-
Wichita、Kansas、美国、67208
- Cancer Center of Kansas, PA - Medical Arts Tower
-
Wichita、Kansas、美国、67214
- Cancer Center of Kansas, PA - Wichita
-
Wichita、Kansas、美国、67214
- CCOP - Wichita
-
Wichita、Kansas、美国、67214
- Via Christi Cancer Center at Via Christi Regional Medical Center
-
Wichita、Kansas、美国、67208
- Associates in Womens Health, PA - North Review
-
Winfield、Kansas、美国、67156
- Cancer Center of Kansas, PA - Winfield
-
-
Louisiana
-
Baton Rouge、Louisiana、美国、70809
- Ochsner Health Center - Bluebonnet
-
Covington、Louisiana、美国、70433
- Ochsner Health Center - Covington
-
New Orleans、Louisiana、美国、70121
- CCOP - Ochsner
-
New Orleans、Louisiana、美国、70121
- Ochsner Cancer Institute at Ochsner Clinic Foundation
-
-
Michigan
-
Adrian、Michigan、美国、49221
- Hickman Cancer Center at Bixby Medical Center
-
Ann Arbor、Michigan、美国、48106-0995
- Saint Joseph Mercy Cancer Center
-
Ann Arbor、Michigan、美国、48106
- CCOP - Michigan Cancer Research Consortium
-
Dearborn、Michigan、美国、48123-2500
- Oakwood Cancer Center at Oakwood Hospital and Medical Center
-
Escanaba、Michigan、美国、49431
- Green Bay Oncology, Limited - Escanaba
-
Flint、Michigan、美国、48503
- Hurley Medical Center
-
Flint、Michigan、美国、48503
- Genesys Hurley Cancer Institute
-
Grosse Pointe Woods、Michigan、美国、48236
- Van Elslander Cancer Center at St. John Hospital and Medical Center
-
Iron Mountain、Michigan、美国、49801
- Dickinson County Healthcare System
-
Jackson、Michigan、美国、49201
- Foote Memorial Hospital
-
Lambertville、Michigan、美国、48144
- Haematology-Oncology Associates of Ohio and Michigan, PC
-
Lansing、Michigan、美国、48912-1811
- Sparrow Regional Cancer Center
-
Livonia、Michigan、美国、48154
- St. Mary Mercy Hospital
-
Monroe、Michigan、美国、48162
- Community Cancer Center of Monroe
-
Monroe、Michigan、美国、48162
- Mercy Memorial Hospital - Monroe
-
Pontiac、Michigan、美国、48341-2985
- St. Joseph Mercy Oakland
-
Port Huron、Michigan、美国、48060
- Mercy Regional Cancer Center at Mercy Hospital
-
Saginaw、Michigan、美国、48601
- Seton Cancer Institute at Saint Mary's - Saginaw
-
Saint Joseph、Michigan、美国、49085
- Lakeside Cancer Specialists, PLLC
-
St. Joseph、Michigan、美国、49085
- Lakeland Regional Cancer Care Center - St. Joseph
-
Warren、Michigan、美国、48093
- St. John Macomb Hospital
-
-
Minnesota
-
Alexandria、Minnesota、美国、56308
-
Bemidji、Minnesota、美国、56601
- MeritCare Bemidji
-
Burnsville、Minnesota、美国、55337
- Fairview Ridges Hospital
-
Coon Rapids、Minnesota、美国、55433
- Mercy and Unity Cancer Center at Mercy Hospital
-
Edina、Minnesota、美国、55435
- Fairview Southdale Hospital
-
Fergus Falls、Minnesota、美国、56537
- Fergus Falls Medical Group, PA
-
Fridley、Minnesota、美国、55432
- Mercy and Unity Cancer Center at Unity Hospital
-
Hutchinson、Minnesota、美国、55350
- Hutchinson Area Health Care
-
Maplewood、Minnesota、美国、55109
- Minnesota Oncology Hematology, PA - Maplewood
-
Maplewood、Minnesota、美国、55109
- HealthEast Cancer Care at St. John's Hospital
-
Minneapolis、Minnesota、美国、55407
- Virginia Piper Cancer Institute at Abbott - Northwestern Hospital
-
Minneapolis、Minnesota、美国、55415
- Hennepin County Medical Center - Minneapolis
-
Robbinsdale、Minnesota、美国、55422-2900
- Hubert H. Humphrey Cancer Center at North Memorial Outpatient Center
-
Rochester、Minnesota、美国、55905
- Mayo Clinic Cancer Center
-
Saint Cloud、Minnesota、美国、56303
- CentraCare Clinic - River Campus
-
Saint Cloud、Minnesota、美国、56303
- Coborn Cancer Center
-
Saint Louis Park、Minnesota、美国、55416
- CCOP - Metro-Minnesota
-
Saint Louis Park、Minnesota、美国、55416
- Park Nicollet Cancer Center
-
Saint Paul、Minnesota、美国、55102
- United Hospital
-
Shakopee、Minnesota、美国、55379
- St. Francis Cancer Center at St. Francis Medical Center
-
St. Paul、Minnesota、美国、55101
- Regions Hospital Cancer Care Center
-
Waconia、Minnesota、美国、55387
- Ridgeview Medical Center
-
Woodbury、Minnesota、美国、55125
- Minnesota Oncology Hematology, PA - Woodbury
-
-
Montana
-
Billings、Montana、美国、59101
- CCOP - Montana Cancer Consortium
-
Billings、Montana、美国、59101
- Hematology-Oncology Centers of the Northern Rockies - Billings
-
Billings、Montana、美国、59101
- Northern Rockies Radiation Oncology Center
-
Billings、Montana、美国、59101
- St. Vincent Healthcare Cancer Care Services
-
Billings、Montana、美国、59107-7000
- Billings Clinic - Downtown
-
Bozeman、Montana、美国、59715
- Bozeman Deaconess Cancer Center
-
Butte、Montana、美国、59701
- St. James Healthcare Cancer Care
-
Great Falls、Montana、美国、59405
- Great Falls Clinic - Main Facility
-
Great Falls、Montana、美国、59405
-
Great Falls、Montana、美国、59405-5309
- Big Sky Oncology
-
Great Falls、Montana、美国、59405
- Sletten Cancer Institute at Benefis Healthcare
-
Havre、Montana、美国、59501
- Northern Montana Hospital
-
Helena、Montana、美国、59601
- St. Peter's Hospital
-
Kalispell、Montana、美国、59901
- Glacier Oncology, PLLC
-
Kalispell、Montana、美国、59901
- Kalispell Medical Oncology at KRMC
-
Missoula、Montana、美国、59804
- Guardian Oncology and Center for Wellness
-
Missoula、Montana、美国、59807-7877
- Montana Cancer Specialists at Montana Cancer Center
-
Missoula、Montana、美国、59807
- Montana Cancer Center at St. Patrick Hospital and Health Sciences Center
-
-
Nebraska
-
Lincoln、Nebraska、美国、68510
- Cancer Resource Center - Lincoln
-
Omaha、Nebraska、美国、68106
- CCOP - Missouri Valley Cancer Consortium
-
Omaha、Nebraska、美国、68122
- Immanuel Medical Center
-
Omaha、Nebraska、美国、68124
- Alegant Health Cancer Center at Bergan Mercy Medical Center
-
Omaha、Nebraska、美国、68131-2197
- Creighton University Medical Center
-
-
North Carolina
-
Rutherfordton、North Carolina、美国、28139
- Rutherford Hospital
-
-
North Dakota
-
Bismarck、North Dakota、美国、58501
- Bismarck Cancer Center
-
Bismarck、North Dakota、美国、58501
- Medcenter One Hospital Cancer Care Center
-
Bismarck、North Dakota、美国、58501
- Mid Dakota Clinic, PC
-
Bismarck、North Dakota、美国、58502
- St. Alexius Medical Center Cancer Center
-
Fargo、North Dakota、美国、58122
- CCOP - MeritCare Hospital
-
Fargo、North Dakota、美国、58122
- MeritCare Broadway
-
Grand Forks、North Dakota、美国、58201
- Altru Cancer Center at Altru Hospital
-
-
Ohio
-
Bowling Green、Ohio、美国、43402
- Wood County Oncology Center
-
Clyde、Ohio、美国、43410
- North Coast Cancer Care - Clyde
-
Dayton、Ohio、美国、45405
- Grandview Hospital
-
Dayton、Ohio、美国、45406
- Good Samaritan Hospital
-
Dayton、Ohio、美国、45409
- David L. Rike Cancer Center at Miami Valley Hospital
-
Dayton、Ohio、美国、45415
- Samaritan North Cancer Care Center
-
Dayton、Ohio、美国、45420
- CCOP - Dayton
-
Elyria、Ohio、美国、44035
- Community Cancer Center
-
Elyria、Ohio、美国、44035
- Hematology Oncology Center
-
Findlay、Ohio、美国、45840
- Blanchard Valley Medical Associates
-
Franklin、Ohio、美国、45005-1066
- Middletown Regional Hospital
-
Greenville、Ohio、美国、45331
- Wayne Hospital
-
Kettering、Ohio、美国、45429
- Charles F. Kettering Memorial Hospital
-
Lima、Ohio、美国、45804
- Lima Memorial Hospital
-
Maumee、Ohio、美国、43537
- St. Luke's Hospital
-
Maumee、Ohio、美国、43537-1839
- Northwest Ohio Oncology Center
-
Norwalk、Ohio、美国、44857
- Fisher-Titus Medical Center
-
Oregon、Ohio、美国、43616
- St. Charles Mercy Hospital
-
Oregon、Ohio、美国、43616
- Toledo Clinic - Oregon
-
Sandusky、Ohio、美国、44870
- North Coast Cancer Care, Incorporated
-
Sylvania、Ohio、美国、43560
- Flower Hospital Cancer Center
-
Tiffin、Ohio、美国、44883
- Mercy Hospital of Tiffin
-
Toledo、Ohio、美国、43608
- St. Vincent Mercy Medical Center
-
Toledo、Ohio、美国、43606
- Toledo Hospital
-
Toledo、Ohio、美国、43614
- Medical University of Ohio Cancer Center
-
Toledo、Ohio、美国、43617
- CCOP - Toledo Community Hospital
-
Toledo、Ohio、美国、43623
- Toledo Clinic, Incorporated - Main Clinic
-
Toledo、Ohio、美国、43623
- St. Anne Mercy Hospital
-
Troy、Ohio、美国、45373-1300
- UVMC Cancer Care Center at Upper Valley Medical Center
-
Wauseon、Ohio、美国、43567
- Fulton County Health Center
-
Wilmington、Ohio、美国、45177
- Clinton Memorial Hospital
-
Xenia、Ohio、美国、45385
- Ruth G. McMillan Cancer Center at Greene Memorial Hospital
-
-
Oklahoma
-
Tulsa、Oklahoma、美国、74136
- Natalie Warren Bryant Cancer Center at St. Francis Hospital
-
-
Oregon
-
Milwaukie、Oregon、美国、97222
- Providence Milwaukie Hospital
-
Portland、Oregon、美国、97216
- Adventist Medical Center
-
Portland、Oregon、美国、97213-2967
- Providence Cancer Center at Providence Portland Medical Center
-
Portland、Oregon、美国、97225
- CCOP - Columbia River Oncology Program
-
Portland、Oregon、美国、97225
- Providence St. Vincent Medical Center
-
-
Pennsylvania
-
Allentown、Pennsylvania、美国、18105
- Morgan Cancer Center at Lehigh Valley Hospital - Cedar Crest
-
Danville、Pennsylvania、美国、17822-0001
- Geisinger Cancer Institute at Geisinger Health
-
Hazleton、Pennsylvania、美国、18201
- Geisinger Hazleton Cancer Center
-
Sayre、Pennsylvania、美国、18840
- Guthrie Cancer Center at Guthrie Clinic Sayre
-
State College、Pennsylvania、美国、16801
- Geisinger Medical Group - Scenery Park
-
Wilkes-Barre、Pennsylvania、美国、18711
- Frank M. and Dorothea Henry Cancer Center at Geisinger Wyoming Valley Medical Center
-
-
South Carolina
-
Anderson、South Carolina、美国、29621
- AnMed Cancer Center
-
Spartanburg、South Carolina、美国、29303
- CCOP - Upstate Carolina
-
Spartanburg、South Carolina、美国、29303
- Gibbs Regional Cancer Center at Spartanburg Regional Medical Center
-
-
South Dakota
-
Rapid City、South Dakota、美国、57701
- Rapid City Regional Hospital
-
Sioux Falls、South Dakota、美国、57105
- Medical X-Ray Center, PC
-
Sioux Falls、South Dakota、美国、57117-5039
- Sanford Cancer Center at Sanford USD Medical Center
-
-
Virginia
-
Fredericksburg、Virginia、美国、22401
- Fredericksburg Oncology, Incorporated
-
-
Washington
-
Vancouver、Washington、美国、98668
- Southwest Washington Medical Center Cancer Center
-
-
Wisconsin
-
Chippewa Falls、Wisconsin、美国、54729
- Marshfield Clinic - Chippewa Center
-
Eau Claire、Wisconsin、美国、54701
- Marshfield Clinic Cancer Care at Regional Cancer Center
-
Eau Claire、Wisconsin、美国、54703-1510
- Midelfort Clinic - Luther
-
Eau Claire、Wisconsin、美国、54702
- Luther Midlelfort Hospital
-
Green Bay、Wisconsin、美国、54307-3508
- St. Vincent Hospital Regional Cancer Center
-
Green Bay、Wisconsin、美国、54301-3526
- Green Bay Oncology, Limited at St. Vincent Hospital Regional Cancer Center
-
Green Bay、Wisconsin、美国、54303
- Green Bay Oncology, Limited at St. Mary's Hospital
-
Green Bay、Wisconsin、美国、54303
- St. Mary's Hospital Medical Center - Green Bay
-
Manitowoc、Wisconsin、美国、54221-1450
- Holy Family Memorial Medical Center Cancer Care Center
-
Marinette、Wisconsin、美国、54143
- Bay Area Cancer Care Center at Bay Area Medical Center
-
Marshfield、Wisconsin、美国、54449
- Marshfield Clinic - Marshfield Center
-
Minocqua、Wisconsin、美国、54548
- Marshfield Clinic - Lakeland Center
-
Oconto Falls、Wisconsin、美国、54154
- Green Bay Oncology, Limited - Oconto Falls
-
Rhinelander、Wisconsin、美国、54501
- Ministry Medical Group at Saint Mary's Hospital
-
Rice Lake、Wisconsin、美国、54868
- Marshfield Clinic - Indianhead Center
-
Stevens Point、Wisconsin、美国、54481
- Marshfield Clinic at Saint Michael's Hospital
-
Sturgeon Bay、Wisconsin、美国、54235
- Green Bay Oncology, Limited - Sturgeon Bay
-
Wausau、Wisconsin、美国、54401
- Marshfield Clinic - Wausau Center
-
Weston、Wisconsin、美国、54476
- Marshfield Clinic - Weston Center
-
Wisconsin Rapids、Wisconsin、美国、54494
- Marshfield Clinic - Wisconsin Rapids Center
-
-
Wyoming
-
Casper、Wyoming、美国、82609
- Rocky Mountain Oncology
-
Sheridan、Wyoming、美国、82801
- Welch Cancer Center at Sheridan Memorial Hospital
-
-
参与标准
资格标准
适合学习的年龄
接受健康志愿者
有资格学习的性别
描述
DISEASE CHARACTERISTICS:
Histologically or cytologically confirmed adenocarcinoma of the pancreas (ductal or undifferentiated)
- Metastatic disease
- No islet cell, acinar cell, or cystadenocarcinomas
- No locally advanced disease
- No history or known presence of CNS metastases
PATIENT CHARACTERISTICS:
- ECOG performance status 0-1
- Life expectancy ≥ 3 months
- ANC ≥ 1,500/mm^3
- Platelet count ≥ 100,000/mm^3
- Total bilirubin ≤ 2 times upper limit of normal (ULN) (patients may be stented)
- AST ≤ 2.5 times ULN
- Creatinine ≤ 2.0 times ULN
- Magnesium ≥ lower limit of normal
- Not pregnant or nursing
- Negative pregnancy test
- Fertile patients must use effective contraception
- Willing to provide a stool specimen
- No malignancy diagnosed within the past 3 years except basal cell or squamous cell skin cancer, prostate cancer (Gleason < 7), or carcinoma in situ of the cervix
- No uncontrolled intercurrent illness including, but not limited to, ongoing or active infection, or psychiatric illness/social situations that would limit compliance with study requirements
- No clinically significant cardiovascular disease (i.e., myocardial infarction, unstable angina, symptomatic congestive heart failure, or serious uncontrolled cardiac arrhythmia) within the past year
- No known positive test(s) for HIV infection, hepatitis C virus, or acute or chronic active hepatitis B infection
- No liver dysfunction from cirrhosis or viral hepatitis
- No enteral hyperalimentation
- No grapefruit or grapefruit juice during the study
PRIOR CONCURRENT THERAPY:
- Recovered from prior therapy
- More than 4 months since prior radiotherapy, immunotherapy, or biologic therapy
- More than 4 weeks since prior and no elective or planned major surgery
- More than 2 weeks since prior minor and no elective or planned surgery
No prior cytotoxic chemotherapy for metastatic disease
Adjuvant chemotherapy for completely resected disease or chemoradiotherapy for locally advanced disease is allowed, provided it was administered > 6 months prior to study entry
- Adjuvant chemotherapy must not have contained an EGFR inhibitor
- Gemcitabine hydrochloride used as either a radiosensitizer or as maintenance therapy is allowed, provided more than 6 months have elapsed since the last day of treatment
- No prior anti-EGFR antibody therapy (e.g., cetuximab) or treatment with small molecule EGFR inhibitors (e.g., gefitinib hydrochloride, erlotinib hydrochloride, or lapatinib)
- No concurrent immunotherapy or radiotherapy
- No other concurrent chemotherapy
- No concurrent colony-stimulating factors during the first course of study therapy
学习计划
研究是如何设计的?
设计细节
- 主要用途:治疗
- 分配:随机化
- 介入模型:并行分配
- 屏蔽:无(打开标签)
武器和干预
参与者组/臂 |
干预/治疗 |
|---|---|
|
有源比较器:Arm A: GE
Patients receive 1000 mg/m^2 gemcitabine hydrochloride IV on days 1, 8, and 15; and 100 mg oral erlotinib hydrochloride on days 1-28.
Treatment repeats every 28 days for 2 courses.
Patients achieving a complete response (CR) after 2 courses receive 2 additional courses of treatment; patients achieving a partial response (PR) receive retreatment as above.
Patients achieving a CR after 4 courses of treatment receive erlotinib hydrochloride until the first disease progression.
After the first progression, patients are retreated with gemcitabine hydrochloride and erlotinib hydrochloride until second progression.
|
鉴于IV
口头给予
|
|
实验性的:Arm B: PGE
Patients receive 1000 mg/m^2 gemcitabine hydrochloride IV on days 1, 8, and 15; 100 mg oral erlotinib hydrochloride on days 1 - 28; and 4.0 mg/kg panitumumab IV on days 1 and 15.
Treatment repeats every 28 days for 2 courses.
Patients achieving a CR after 2 courses receive 2 additional courses of treatment; patients achieving a PR receive retreatment as above.
Patients achieving a CR after 4 courses of treatment receive erlotinib hydrochloride and panitumumab until the first disease progression.
After the first progression, patients are retreated with gemcitabine hydrochloride, erlotinib hydrochloride, and panitumumab until second progression.
|
鉴于IV
口头给予
鉴于IV
|
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Overall Survival
大体时间:Up to 2 years
|
Overall Survival is defined as the time from registration to death due to any cause.
The estimate will be done using the Kaplan-Meier method.
The primary goal of this trial is to compare the experimental arm (Arm B) to the standard arm (Arm A).
The primary analysis will be a comparison of Arm A to Arm B using a one-sided log-rank test between the 2 Kaplan-Meier curves.
|
Up to 2 years
|
次要结果测量
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Confirmed Response Rate
大体时间:Up to 2 years
|
Evaluated using RECIST version 1.0.
Confirmed tumor response rate was defined as achieving partial response (PR) or complete response (CR) in two consecutive assessments at least 6 weeks apart.
CR is complete disappearance of all target lesions and PR is at least a 30% decrease in the sum of longest diameter (LD) of target lesions, taking as reference baseline sum LD.
The confirmed response rate is reported as the number of participants with confirmed responses divided by the number of evaluated participants.
|
Up to 2 years
|
|
Progression-free Survival
大体时间:Up to 2 years
|
Progression-free survival is defined as the time from randomization to documentation of disease progression or death, whichever comes first.
Progression is defined as at least a 20% increase in the sum of longest dimension (LD) of target lesions taking as reference the smallest sum LD recorded since the treatment started or the appearance of one or more new lesions.
The distribution of progression-free survival will be estimated using the method of Kaplan-Meier.
The progression-free survival curves will be compared between the 2 arms using a log-rank test.
|
Up to 2 years
|
|
Time to Treatment Failure
大体时间:Up to 2 years
|
Time to treatment failure is defined to be the time from the date of randomization to the date at which the patient is removed from treatment due to progression, adverse events, or refusal.
If the patient is considered to be a major treatment violation or is taken off study as a nonprotocol failure, the patient will be censored on the date they are removed from treatment.
The time to treatment failure will be estimated using the method of Kaplan-Meier.
|
Up to 2 years
|
|
Frequency and Severity of Observed Adverse Effects
大体时间:Up to 2 years
|
Patients are assessed for Adverse events each cycle using the Common Terminology Criteria for Adverse Events version 3.0 (CTCAE v3.0). The maximum grade for each type of adverse event will be recorded for each patient, and tables will be reviewed to determine adverse event patterns. The number of patients in each arm that reported a grade 3 or higher adverse event and a grade 4 or higher adverse event are reported. A complete listing of all adverse events is reported in the Adverse Events section. |
Up to 2 years
|
合作者和调查者
调查人员
- 学习椅:George P. Kim, MD、Mayo Clinic
出版物和有用的链接
研究记录日期
研究主要日期
学习开始
初级完成 (实际的)
研究完成 (实际的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (估计)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
与本研究相关的术语
其他相关的 MeSH 术语
其他研究编号
- NCCTG-N064B
- NCI-2009-01089 (注册表标识符:CTRP (Clinical Trials Reporting System))
- CDR0000571863 (注册表标识符:PDQ (Physician Data Query))
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.